DRUG NEWS NEW DRUGS. booster injection. Adverse reactions have included headache, fatigue, and pain at the injection site. Source: FDA, July 8, 2011

Size: px
Start display at page:

Download "DRUG NEWS NEW DRUGS. booster injection. Adverse reactions have included headache, fatigue, and pain at the injection site. Source: FDA, July 8, 2011"

Transcription

1 NEW DRUGS Xarelto Reduces Risk Of Blood Clots After Surgery The FDA has approved rivaroxaban (Xarelto, Janssen) to reduce the risk of blood clots, deep vein thrombosis (DVT), and pulmonary embolism (PE) following knee- or hip-replacement surgery. The tablets are taken once daily. Patients who are undergoing a knee replacement should take the drug for 12 days; patients who are undergoing a hip replacement should take it for 35 days. In a study involving hip-replacement surgery, venous thromboembolic events (VTEs) developed in 1.1% of rivaroxaban patients and in 3.9% of those receiving enoxaparin (Lovenox, Sanofi-aventis). In another study, 2% of riva roxaban participants developed VTE compared with 8.4% of those receiving enoxaparin. Bleeding was the most common side effect. Other anticlotting drugs include fondaparinux (Arixtra, GlaxoSmithKline), dalteparin (Fragmin, Pfizer), warfarin (Coumadin, Bristol-Myers Squibb), and heparin. Rivaroxaban is also discussed in this month s Continuing Education Credit article on atrial fibrillation (page 525). Source: FDA, July 5, 2011 Brilinta, an Antiplatelet Agent For Acute Coronary Syndromes AstraZeneca has been granted approval of its heart drug, ticagrelor (Brilinta), which may become a strong rival of clopidogrel (Plavix, Bristol-Myers Squibb/Sanofi-aventis). Ticagrelor is indicated to reduce cardiovascular deaths and heart attacks in patients with acute coronary syndromes (ACS). The drug prevents the formation of new blood clots, thus maintaining blood flow to help decrease the risk of future cardiovascular events. A boxed warning mentions a risk of bleeding and reduced effectiveness if the drug is taken with more than 100 mg of aspirin per day. In clinical trials, ticagrelor was more effective than clopidogrel in preventing heart attacks and death, but that advantage was seen with aspirin maintenance doses of 75 to 100 mg, according to the FDA. Ticagrelor was approved in Europe as Brilique. A Risk Evaluation and Mitigation Strategy (REMS) and a patient Medication Guide are provided. Sources: Bloomberg; Fierce Biotech; Heartwire, July 20, 2011 Generic Arixtra Dr. Reddy s has announced the FDA s final approval of its Abbreviated New Drug Application (ANDA) for fondaparinux sodium injection, the generic version of GlaxoSmithKline s Arixtra, an anticoagulant. The approval covers strengths of 2.5 mg/0.5 ml, 5 mg/0.4 ml, 7.5 mg/0.6 ml, and 10 mg/0.8 ml in prefilled, color-coded, single-dose syringes with an automatic needle safety device. Fondaparinux, an anticoagulant, is a complex molecule that is difficult to make on a large scale, according to Dr. Reddy s. The company will be using a patented process developed by Alchemia Ltd. Sources: Dr. Reddy s/alchemia Ltd., Associated Press, July 13, 2011 NEW INDICATIONS Boostrix Vaccine For Oldest Age Group Boostrix (GlaxoSmithKline) has been approved to prevent tetanus, diphtheria, and pertussis in people 65 years of age and older. The vaccine was first approved in 2005 for adolescents 10 through 18 years of age. In 2008, the approval was extended to include adults 19 through 64 years of age. Boostrix is given as a single-dose booster injection. Adverse reactions have included headache, fatigue, and pain at the injection site. Source: FDA, July 8, 2011 Lialda to Maintain Remission Of Ulcerative Colitis Shire s once-daily mesalamine (Lialda) delayed-release tablets are now approved for the maintenance of remission in patients with ulcerative colitis. In 2007, mesalamine was approved for the induction of remission in patients with active, mild-to-moderate ulcerative colitis. Source: Shire, July 19, 2011 NEW FORMULATIONS Tamper-Resistant Oxycodone (Oxecta) for Pain Pfizer and Acura have announced the FDA s approval of an abuse-resistant form of oxycodone HCl tablets (Oxecta) for patients with acute and chronic moderate-to-severe pain. An immediate-release Schedule II medication, Oxecta was previously under development as Acurox, which included niacin to deter oral abuse. Pfizer acquired Oxecta when it merged with King Pharmaceuticals in Aversion technology is designed to discourage tampering associated with opioid abuse and misuse, such as crushing, chewing, snorting, or injecting. The ingredients form a gel if the tablet is mixed to create a solution, and they irritate the nose if the product is crushed and inhaled. The drug breaks down into crumbled chunks instead of a powder if it is crushed, and it turns sudsy if it is mixed with liquid and drawn into a syringe. Oxecta should not be used in a feeding tube because it may obstruct the tube. Pfizer will be conducting a study to learn whether the product decreases the consequences of abuse and misuse. Sources: Bloomberg News, MedPage Today, June 20, 2011 Vol. 36 No. 8 August 2011 P&T 469

2 Lazanda (Fentanyl) Nasal Spray Relieves Cancer Pain Fentanyl nasal spray (Lazanda, Ar - chimedes) has been approved for the management of breakthrough pain in patients 18 years of age and older who have been receiving opioids for under - lying persistent cancer pain. In Europe, Lazanda is marketed as fentanyl pectin nasal spray (PecFent). The drug is delivered as a fine mist spray to the nasal membrane. Each spray forms a gel when it contacts the nasal mucosa; the active ingredient is then rapidly absorbed across the mucus membrane and directly into the bloodstream. Lazanda is contraindicated in opioid non-tolerant patients and in those with acute or postoperative pain. The product will include a Risk Evaluation and Mitigation Strategy (REMS) program. Fentanyl is a Schedule II controlled substance. Sources: Archimedes, June 30, 2011; Medical News Today, July 1, 2011 Rules for Generic Labels Are Less Stringent The Supreme Court has ruled that generic drug companies do not share the same level of responsibility as their brand-name counterparts in updating warning labels about new risks. For instance, consumers may sue the brandname drug manufacturer for inadequate warnings, but they may not sue a generic drug manufacturer for the same problem. Generic drug companies must use the same warning labels as the brand-name medications and may not independently change the labels. However, these companies are caught in a bind: they can comply with a state law requiring them to change their labels or with the federal law prohibiting changes, but not both. Given this dilemma, federal law preempts state law under the Constitution s supremacy clause. Sources: Cable News Network (CNN); The New York Times, June 23, 2011 Alert for Colistimethate The American Society of Health- System Pharmacists (ASHP) and the Institute for Safe Medication Practices (ISMP) have warned that potentially fatal dosing errors have occurred with the antibiotic colistimethate for injection. The use of this drug has been increasing because of its value as a last-resort treatment for multidrug-resistant organisms. Colistimethate is a prodrug; in the U.S., the strengths of all colistimethatefor-injection products are labeled in terms of the base drug (colistin), not the prodrug. The label expresses the strength as 150 mg of colistin base per vial. Dosing information is also expressed in terms of the colistin base. However, in some journal and Internet references, dosing information is based on the prodrug. Thus, the colistimethate dose has sometimes been ordered but may be confused as a colistin dose. This causes the dose to be approximately 2.5 times higher than intended. The alert provides information on preventing incorrect dosing of the drug, developing dose limits, restricting prescribing to infectious-disease specialists, and monitoring renal function. Sources: FDA; ASHP; ISMP; June 30, 2011 Flu Vaccines for The new FDA-approved influenza vaccine formulations for the influenza season will include the same virus strains that were used for the flu season: Afluria (CSL Limited); Fluarix (GlaxoSmithKline); FluLaval (ID Biomedical Corp.); FluMist (Med- Immune); Fluvirin (Novartis); and Fluzone, Fluzone High-Dose, and Fluzone Intradermal (Sanofi Pasteur). Fluzone Intradermal, approved in May 2011, will be available for people 18 to 64 years of age. This vaccine is delivered into the skin, rather than the muscle, with a very small needle. The strains selected are A/California/7/09 (H1N1)-like virus (pandemic [H1N1] 2009 influenza virus); A/Perth/ 16/2009 (H3N2)-like virus; and B/Brisbane/60/2008-like virus. It is always possible that an imperfect match may occur between the virus strains that are predicted to circulate and the virus strains that eventually cause the most illnesses. However, even if the vaccine and the circulating strains do not match exactly, the vaccine may reduce the severity of the illness or may prevent influenza-related complications. The Centers for Disease Control and Prevention (CDC) recommends that everyone six months of age and older receive an annual flu vaccination. Sources: FDA, July 18, 2011; CDC, Most Drugs Do Not Improve Parkinson s Psychosis Although antipsychotic drugs are commonly used in Parkinson s disease (PD), they can worsen parkinsonism. Evidence of their efficacy is limited, and their use in patients with dementia sometimes increases the risk of death. In a study of patients with PD from the University of Pennsylvania, about 30% of the prescriptions were for high-potency medications that can actually cause harmful effects. For 98% of prescriptions, there was no proof that the drugs im - proved symptoms of psychosis in the patients. Only one drug, clozapine (Clo - zaril, Novartis), does improve psychotic symptoms in PD psychosis, but only 2% of patients received prescriptions for it. In fiscal year 2008, 50% of patients with 470 P&T August 2011 Vol. 36 No. 8

3 PD who also had a diagnosis of psychosis received an antipsychotic drug. Quetiapine (Seroquel, AstraZeneca) was the drug that was prescribed most frequently (in 66% of patients). Comparing fiscal year 2008 with fiscal year 2002, the use of these medica tions in PD was unchanged. Decreases in risperidone (Risperdal, Jan - ssen) and olanzapine (Zyprexa, Eli Lilly) were offset by an increase in quetiapine and the introduction of aripiprazole (Abilify, Bristol-Myers Squibb/Otsuka). The frequency of use of these agents has not changed since the FDA issued black-box warnings for anti psychotic agents in patients with dementia. Because psychosis and dementia often coexist in PD patients, risks associated with the use of atypical antipsychotic drugs in this population need to be assessed. Sources: Reuters, July 19, 2011; Arch Neurol 2011;68(7): Drug Events and Pregnancy Autism and Antidepressants In a preliminary study of pregnant women, those who took antidepressants had a slightly increased risk of having a child with autism. From 2006 to 2008, anti depressant use grew to include about 7.5% of pregnant women, an increase from 5% in 2000 to Until 1990, fewer than 1% of pregnant women used anti - depressants in the first trimester. Results indicated a doubling in the risk of autism if the mother took an anti - depressant at any point in the year before delivery. The risk tripled if she filled the prescription during the first trimester. The findings did not address whether antidepressants caused autism, but the drugs might have had adverse outcomes in children. The researchers identified 298 children with autism or a similar disorder. They then examined the characteristics of the mothers retrospectively. The children and mothers were compared with 1,507 non-autistic children and their mothers. The link between autism in the child and the mother s use of antidepressants predominantly the selective serotonin reuptake inhibitors (SSRIs) remained even after other factors were considered that might have been related to either condition, such as maternal age, ethnicity, education, birth weight, and place of birth. The researchers also sought to determine whether the mother s mental state or the antidepressants were linked with autism. The results indicated an association with treatment but not with the mother s mental state. Although the number of children exposed to SSRIs before birth in this population was low, exposure (especially during the first trimester) may modestly increase the risk of autism spectrum disorder. The potential risk associated with exposure must be balanced with the risk of untreated mental health disorders in the mother. Sources: Am J Obstet Gynecol July 4, 2011 (online); The Wall Street Journal, July 5, 2011 Birth Defects and SSRIs About 3% to 6% of women take selective serotonin reuptake inhibitors (SSRIs) for depression during pregnancy, say researchers from Finland. Does that put them at risk of giving birth to babies with congenital anomalies, such as septal heart defects, anencephaly, and limb defects? Although a small increased risk of congenital cardiovascular anomalies has been suggested with fluoxetine (Prozac, Eli Lilly) and paroxetine (Paxil, GlaxoSmithKline), no direct teratogen - icity for any of the SSRIs has been established. The researchers performed a retrospective cohort study using data from national registers between 1996 and 2006 on 635,583 births, congenital anomalies, and terminations of pregnancy owing to severe fetal anomalies. Offspring who were exposed to SSRIs (n = 6,976) during the first tri mes ter were compared with offspring who had not been exposed to these drugs. At first, congenital anomalies appeared to be more common among offspring exposed to SSRIs, but that difference did not remain significant after the team adjusted for confounding factors. Variables that were independently associated with birth defects included maternal age, year of pregnancy (2006 compared with 1996), maternal diabetes, and prescriptions for other psychiatric drugs. Nonetheless, there was an increased risk of ventricular septal defects after exposure to fluoxetine, even when newborns in the neonatal care unit were excluded from the analysis. The risk of right ventricular outflow tract defects was increased with exposure to paroxetine. Citalopram (Celexa, Forest) was associated with neural tube defects. Most striking was the ten-fold jump in fetal alcohol spectrum disorders in offspring of mothers using SSRIs compared with offspring who had not been exposed. Women taking SSRIs were 20 times more likely to have purchased other psychiatric drugs, compared with women who did not purchase SSRIs during pregnancy. When the researchers considered only other psychiatric drugs, the association between SSRIs and major congenital anomalies became insignificant. When they categorized polytherapy as consisting of first-trimester use of both SSRIs and other psychiatric drugs, exposure was significantly associated with congenital anomalies. Exposure to fluoxetine and paroxetine in early pregnancy was associated with a small but established risk of cardiovascular anomalies. The researchers advise follow-up of pregnant women who drink alcohol, smoke, and use other psychiatric drugs while they are taking SSRIs. Vol. 36 No. 8 August 2011 P&T 471

4 Source: Obstet Gynecol 2011;118: (July) Chantix May Increase Heart Problems Smokers who take Pfizer s varenicline (Chantix) might be increasing their risk of heart problems. Dr. Sonal Singh at Johns Hopkins University warned that this drug, used as an aid in smoking cessation, might raise the risk of heart attacks and irregular heartbeats. Varenicline blocks nicotine receptors in the brain so that cigarettes become less enjoyable. Today, almost 2,000 cases are pending in the federal court system that attribute adverse neuropsychiatric effects to the drug. A warning label mentions the possibility of behavioral changes, hostility, agitation, depressed mood, and suicidal thoughts or actions. A boxed warning mentions the possibility of psychological events. Varenicline is banned for use by pilots and air-traffic controllers, because it may cause loss of consciousness and blackouts. It is also not recommended for truck and bus drivers. Researchers examined data from clinical trials involving 8,216 healthy people who received either varenicline or a pla - cebo. Heart problems were reported in 1.06% who took varenicline and in 0.82% of placebo participants. Although the difference appeared to be 0.24%, the actual risk was calculated at 72%. Dr. Singh said he hesitates to prescribe the drug, because smokers already have cardio - vascular (CV) risks, and other options (counseling, nicotine replacements, and bupropion) are available. Pfizer said that the study had several limitations mainly that the number of heart problems was so small that it raised concerns about the reliability of the study s conclusions. In June, the FDA added a warning that varenicline might be associated with a small, increased risk of CV adverse events in patients who already have CV disease. Sources: Can Med Assoc J, ca, July 4, 2011; WebMD, Salient News, July 6, 2011, Label Change: Lower ESA Doses For Lower Cardiovascular Risk The FDA has recommended more conservative dosing guidelines for erythropoiesis-stimulating agents (ESAs) when they are used to treat anemia in patients with chronic kidney disease (CKD) because of the increased risks of cardiovascular (CV) events such as stroke, thrombosis, and death. ESAs are synthetic versions of erythropoietin, which stimulates the cells in bone marrow to produce red blood cells (RBCs). These drugs are approved to treat some forms of anemia resulting from CKD, chemotherapy, and other conditions. ESAs include epoetin alfa (Epo - gen, Amgen; Procrit, Ortho Biotech) and darbepoetin alfa (Aranesp, Amgen). The new recommendations are being added to the boxed warning and other sections of the package insert. The lowest possible dose should be used to reduce the need for RBC transfusions. Until now, labels for ESAs have recommended doses to achieve and maintain hemoglobin (Hb) levels within the range of 10 to 12 g/dl in patients with CKD. In the new package insert, this targeted range is removed. For patients with anemia of CKD who are not on dialysis, ESA therapy may begin only when the Hb level is below 10 g/dl. If the Hb level exceeds 10 g/dl, the dose should be reduced or interrupted. For patients with anemia of CKD who are on dialysis, ESAs can be started when the Hb level is below 10 g/dl. If the Hb level approaches or exceeds 11 g/dl, the dose should be reduced or interrupted. The changes are based on data from TREAT (Trial to Reduce Cardiovascular Events with Aranesp Therapy), which showed that ESAs, when used to target Hb levels higher than 11 g/dl, increased the risk of adverse CV events and provided no additional benefit. The FDA has asked Amgen to conduct more trials. Changes are being added to the current Risk Evaluation and Mitigation Strategy (REMS) for ESAs. Source: FDA, June 24, 2011 Antirheumatic Drugs May Improve Insulin Resistance Rheumatoid arthritis (RA) and psoriasis have been associated with diabetes and insulin resistance. Disease-modifying antirheumatic drugs (DMARDs) that act directly against the inflammatory response, such as tumor necrosis factor (TNF) inhibitors and hydroxychloro - quine, may improve insulin resistance and reduce the risk of diabetes mellitus. Doctors from Brigham and Women s Hospital in Boston examined the relationship between DMARDs and newly diagnosed diabetes. Their study involved 13,905 patients with RA or psoriasis. All participants had at least two diagnoses and one filled prescription for a DMARD before the start of follow-up. The researchers estimated the relative risk of diabetes according to the drug: TNF inhibitors, methotrexate, hydroxychloro - quine, and other nonbiologic DMARDs such as sulfasalazine (Azulfidine, Pfi - zer), cyclosporine (Neoral, Sand immune, Novartis), and azathioprine (Azasan, Salix; Imuran, Prometheus). During a mean follow-up period of six months, the researchers identified 267 newly diagnosed cases of diabetes: 55 cases among patients using nonbiologic DMARDs, 80 cases among those using TNF inhibitors, 82 cases among those taking methotrexate, and 50 cases among those using hydroxychloroquine (5,682 treatment episodes). Patients who continued on page P&T August 2011 Vol. 36 No. 8

5 in the mothers, scientists hope to set the children on a more healthful path for life. In animal studies, reducing maternal cholesterol levels in pregnancy with cholestyramine (Questran, Par) or with high doses of vitamin E decreased the offspring s chance of developing hypercholesterolemia, which is passed from the mother to the fetus and is a risk factor for atherosclerosis. The U.K. study is aimed at reducing the risk of obesity in children born to obese mothers. So far, about 15 patients have enrolled, and about 400 women are expected to be recruited over the next two or more years. In the study, women who are obese but nondiabetic will receive metformin (Glucophage, Bristol- Myers Squibb) during their pregnancy. Obese women, even those without diabetes, tend to have hyperglycemia during pregnancy. Glucose passes through the placenta to the fetus, causing the fetus to work harder to produce more insulin to handle higher levels of sugar. These newborns tend to be born larger (weighing nine pounds or more) and need to produce more insulin, because their bodies expect to take in higher levels of glucose. Heavy babies have a higher risk of obesity, heart problems, and diabetes in later childhood and adulthood. The researchers expect metformin to lower maternal glucose levels; this in turn should reduce the amount of glucose transmitted to the fetus. The hopedfor outcome is a smaller newborn with more efficient insulin metabolism. Although the trial raises a question about whether pregnant women should take drugs that they don t actually need, metformin is considered safe in pregnant women; in the U.K., it is the first-line treatment for diabetic pregnant women. Obesity in pregnant women is a major risk factor in stillbirths, maternal death, and blood clots, as well as joint pain, nausea, and heartburn. Early intervencontinued from page 472 switched to nonbiologic DMARDs had the highest incidence of diabetes, and those using TNF inhibitors or hydroxychloroquine had the lowest rates. There was a suggestion of a reduced risk with methotrexate, but it was found to be not statistically significant. The investigators say that the results should be considered hypothetical. Several earlier studies had suggested that TNF inhibitors improved insulin metabolism among patients with RA. Animal studies had also indicated that hydroxychloroquine and the closely related antimalarial agent chloroquine had direct effects on pancreatic islet cells. In light of these previous results, the researchers say that their study supports the potential role for systemic immunosuppression in preventing and controlling diabetes. Source: JAMA 2011;305: Don t Stop Low-Dose Aspirin Heart patients who are taking a daily aspirin (81 mg) are advised not to quit their regimen. In a study funded by Astra Zeneca and led by Dr. Luis Garcia Rodriguez in Spain, patients who stopped taking low-dose aspirin had a higher risk of a heart attack and related fatalities. The researchers used a British database of 39,513 subjects, 50 to 84 years of age, who began taking the drug between 2000 and During an average follow-up of 3.2 years, 1,222 patients had heart attacks or died of coronary-related causes. Within this group, 12% had stopped their regimen. Compared with patients who continued taking aspirin, those who quit therapy had a 50% greater risk for a heart attack or death. Over a period of one year, it was estimated that quitting aspirin might have accounted for four extra nonfatal heart attacks in every 1,000 people. The authors say that the potential benefits of aspirin probably outweigh the risk of gastrointestinal bleeding, which many patients cite as a reason for discontinuation. Sources: BMJ, July 19, 2011; heartwire, July 20, 2011; The Philadelphia Inquirer, July 25, 2011 RESEARCH NEWS Rilutek, an ALS Drug, May Help Bipolar Depression One cause of depression is thought to be dysregulation of glutamate, the most abundant excitatory neurotransmitter in the body. Riluzole (Rilutek, Sanofiaventis), commonly used to slow the progression of amyotrophic lateral sclerosis (ALS, or Lou Gehrig s disease), reduces the release of glutamate while increasing its uptake. The drug also may delay the need for a tracheostomy, although it is not a cure for ALS. In some studies, riluzole was effective in treating acute bipolar depression alone or in combination with other antidepressants. Riluzole and other drugs that target glutamate reduce the risk of triggering a switch to mania. The cause of ALS is unknown. One hypothesis is that motor neurons may be injured by glutamate. Source: Brain & Behavior, Spring 2011, Metformin for Mothers, Healthier Babies The United Kingdom has launched the first trial of an effort to affect the intra - uterine environment, and thus the development, of childhood obesity in the womb. A British study just getting under way aims to use medication to change the environment in the uteri of pregnant women in order to improve their children s health later in life, a concept known as fetal (developmental) programming. By adding drugs or nutritional supplements and changing the diet to influence metabolism, digestion, and temperature Vol. 36 No. 8 August 2011 P&T 477

6 tion in the womb may be more effective in preventing obesity later in life than advising children and adults to eat better and exercise more. Source: The Wall Street Journal, July 5, 2011 NEW MEDICAL DEVICES Marvin M. Goldenberg, PhD, RPh, MS Name: Inform Dual ISH Test Manufacturer: Ventana Medical Systems, Tucson, Ariz. Approval Date: June 14, 2011 Purpose: About 20% of women with breast cancer have tumors that are HER2-positive and are, therefore, candidates for trastuzumab (Herceptin, Genentech). Deciding who might be a good fit may become easier, with the approval of a new genetic screening test. Description: The test measures the number of copies of the HER2 gene in tumor tissue and is designed to detect amplification of the HER2 gene by light microscopy. The pathologist uses twocolor chromogenic in situ hybridization (ISH) in formalin-fixed, paraffin-embedded human breast and gastric tumors. Benefit: The pathologist can see and count copies of chromosome 17 and HER2 genes on the same slide. In the past, HER2 amplification could be measured only with the fluorescence microscope. With the new test, HER2 and chromosome 17 signals can be viewed directly under a microscope and for longer periods of time. In a study of tumor samples from 510 patients with breast cancer, the test confirmed the number of copies of the gene in 96% of the HER2-positive samples and identified 92.3% of the HER2-negative tumor samples. Because patients whose tumors are HER2-negative are not usually candidates for trastuzumab, the test can assist physicians in selecting an appropriate treatment. Sources: FDA and Medscape Today, June 14, 2011, view article/ Name: Pinnacle CoMplete Acetabular Hip System Manufacturer: DePuy Orthopaedics/ Johnson & Johnson, Warsaw, Ind. Approval Date: June 14, 2011 Purpose: This single-use device is intended for uncemented fixation and as a primary joint replacement prosthesis in total hip arthroplasty. Patients must be skeletally mature and must be experiencing at least moderate pain in the hip joint from non-inflammatory degenerative joint disease, osteoarthritis, or posttraumatic arthritis. Description: As the first ceramic-onmetal total hip replacement system, the device combines a ceramic ball and a metal socket. The femoral head portion of the implant is made of ceramic, and the acetabular (socket) component is a metal alloy. Ceramic-on-ceramic, ceramic-onpolyethylene, metal-on-polyethylene, and metal-on-metal hip-replacement devices have been approved previously. Benefit: Pain is reduced, and the patient s ability to move is restored. In a two-year trial, no difference was observed between patients who received the ceramic-on-metal system and those who received a metal-on-metal implant. Two patients who received the Pinnacle product needed revision sur gery to replace the new implant, compared with three control patients who required a second surgery. Contraindications: The Pinnacle system should not be used in patients with an infection that could spread to other areas of the body; osteoporosis or severe osteopenia; a weakened or deformed upper femur; skeletal immaturity; nerve or muscle disease that could affect walking or weight bearing; cancer; renal impairment; or an allergy or sensitivity to metal. Pregnant women are not candidates for the device because of the unknown effects of metal ions on the fetus. Sources: FDA, June 13, 2011; Med Page Today, Name: Azficel-T (lavív) Manufacturer: Fibrocell Science, Inc., Exton, Pa. Approval Date: June 21, 2011 Purpose: This autologous dermal filler is used to improve the appearance of moderate-to-severe wrinkles of the naso labial fold in adults. Description: The patient s own skin cells (fibroblasts) are extracted from behind the ear. The cells are sent to the company s laboratory, where they undergo a multiplication process for about three months. In normal skin, fibroblasts help to produce collagen. The cells are then frozen until needed. Over a series of three treatment sessions, typically three to six weeks apart, the cells are injected into the patient s nasolabial folds to reduce the appearance of smile lines. Benefit: In two phase 3 studies, more patients responded positively to lavív than to placebo. lavív improved the appearance of nasolabial fold wrinkles for the six months of follow-up after the third and final treatment. Injection-site re - actions usually resolved within one week. Because the biological process works over a period of time, laviv can provide natural-looking results. Fibrocell plans to set up a registry to further evaluate the safety of the filler. Precaution: laviv should be admini - stered only by dermatologists and plastic surgeons who complete a companysponsored training program in biopsy collection, shipping procedures, product preparation, and injection technique. Specialists are also taught how to ensure that patients receive their own cells. Sources: FDA, Drugs.com, and Medscape Today, June 22, 2011, 478 P&T August 2011 Vol. 36 No. 8

MEDICATION GUIDE. PROCRIT (PRO KRIT) (epoetin alfa)

MEDICATION GUIDE. PROCRIT (PRO KRIT) (epoetin alfa) MEDICATION GUIDE PROCRIT (PROKRIT) (epoetin alfa) Read this Medication Guide: before you start PROCRIT. if you are told by your healthcare provider that there is new information about PROCRIT. if you are

More information

Preconception Clinical Care for Women Medical Conditions

Preconception Clinical Care for Women Medical Conditions Preconception Clinical Care for Women All women of reproductive age are candidates for preconception care; however, preconception care must be tailored to meet the needs of the individual. Given that preconception

More information

What Does Pregnancy Have to Do With Blood Clots in a Woman s Legs?

What Does Pregnancy Have to Do With Blood Clots in a Woman s Legs? Patient s Guide to Prevention of Blood Clots During Pregnancy: Use of Blood-Thinning A Patient s Guide to Prevention of Blood Clots During Pregnancy: Use of Blood-Thinning Drugs to Prevent Abnormal Blood

More information

The largest clinical study of Bayer's Xarelto (rivaroxaban) Wednesday, 14 November 2012 07:38

The largest clinical study of Bayer's Xarelto (rivaroxaban) Wednesday, 14 November 2012 07:38 Bayer HealthCare has announced the initiation of the COMPASS study, the largest clinical study of its oral anticoagulant Xarelto (rivaroxaban) to date, investigating the prevention of major adverse cardiac

More information

Bayer Initiates Rivaroxaban Phase III Study to Support Dose Selection According to Individual Benefit-Risk Profile in Long- Term VTE Prevention

Bayer Initiates Rivaroxaban Phase III Study to Support Dose Selection According to Individual Benefit-Risk Profile in Long- Term VTE Prevention Investor News Not intended for U.S. and UK Media Bayer AG Investor Relations 51368 Leverkusen Germany www.investor.bayer.com Long-term prevention of venous blood clots (VTE): Bayer Initiates Rivaroxaban

More information

Bipolar Disorder. Mania is the word that describes the activated phase of bipolar disorder. The symptoms of mania may include:

Bipolar Disorder. Mania is the word that describes the activated phase of bipolar disorder. The symptoms of mania may include: Bipolar Disorder What is bipolar disorder? Bipolar disorder, or manic depression, is a medical illness that causes extreme shifts in mood, energy, and functioning. These changes may be subtle or dramatic

More information

ABOUT XARELTO CLINICAL STUDIES

ABOUT XARELTO CLINICAL STUDIES ABOUT XARELTO CLINICAL STUDIES FAST FACTS Xarelto (rivaroxaban) is a novel, oral direct Factor Xa inhibitor. On September 30, 2008, the European Commission granted marketing approval for Xarelto for the

More information

Prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (AF) with one or more risk factors

Prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (AF) with one or more risk factors News Release For use outside the US and UK only Bayer Pharma AG 13342 Berlin Germany Tel. +49 30 468-1111 www.bayerpharma.com Bayer s Xarelto Approved in the EU for the Prevention of Stroke in Patients

More information

Summary of the risk management plan (RMP) for Aripiprazole Pharmathen (aripiprazole)

Summary of the risk management plan (RMP) for Aripiprazole Pharmathen (aripiprazole) EMA/303592/2015 Summary of the risk management plan (RMP) for Aripiprazole Pharmathen (aripiprazole) This is a summary of the risk management plan (RMP) for Aripiprazole Pharmathen, which details the measures

More information

MAJOR DEPRESSION DURING CONCEPTION AND PREGNANCY: A Guide for Patients and Families

MAJOR DEPRESSION DURING CONCEPTION AND PREGNANCY: A Guide for Patients and Families MAJOR DEPRESSION DURING CONCEPTION AND PREGNANCY: A Guide for Patients and Families David A. Kahn, MD, Margaret L. Moline, PhD, Ruth W. Ross, MA, Lee S. Cohen, MD, and Lori L. Altshuler, MD www.womensmentalhealth.org

More information

Investor News. Not intended for U.S. and UK media

Investor News. Not intended for U.S. and UK media Investor News Not intended for U.S. and UK media Bayer AG Investor Relations 51368 Leverkusen Germany www.investor.bayer.com Bayer s Xarelto (Rivaroxaban) Approved for the Treatment of Pulmonary Embolism

More information

INTRODUCTION Thrombophilia deep vein thrombosis DVT pulmonary embolism PE inherited thrombophilia

INTRODUCTION Thrombophilia deep vein thrombosis DVT pulmonary embolism PE inherited thrombophilia INTRODUCTION Thrombophilia (Hypercoagulability) is a condition in which a person forms blood clots more than normal. Blood clots may occur in the arms or legs (e.g., deep vein thrombosis DVT), the lungs

More information

Statistics of Type 2 Diabetes

Statistics of Type 2 Diabetes Statistics of Type 2 Diabetes Of the 17 million Americans with diabetes, 90 percent to 95 percent have type 2 diabetes. Of these, half are unaware they have the disease. People with type 2 diabetes often

More information

MEDICATION GUIDE ELIQUIS (ELL eh kwiss) (apixaban) tablets

MEDICATION GUIDE ELIQUIS (ELL eh kwiss) (apixaban) tablets MEDICATION GUIDE ELIQUIS (ELL eh kwiss) (apixaban) tablets What is the most important information I should know about ELIQUIS? For people taking ELIQUIS for atrial fibrillation: People with atrial fibrillation

More information

Causes, incidence, and risk factors

Causes, incidence, and risk factors Causes, incidence, and risk factors Insulin is a hormone produced by the pancreas to control blood sugar. Diabetes can be caused by too little insulin, resistance to insulin, or both. To understand diabetes,

More information

Insulin is a hormone produced by the pancreas to control blood sugar. Diabetes can be caused by too little insulin, resistance to insulin, or both.

Insulin is a hormone produced by the pancreas to control blood sugar. Diabetes can be caused by too little insulin, resistance to insulin, or both. Diabetes Definition Diabetes is a chronic (lifelong) disease marked by high levels of sugar in the blood. Causes Insulin is a hormone produced by the pancreas to control blood sugar. Diabetes can be caused

More information

Liver Disease & Hepatitis Program Providers: Brian McMahon, MD, Steve Livingston, MD, Lisa Townshend, ANP. Primary Care Provider:

Liver Disease & Hepatitis Program Providers: Brian McMahon, MD, Steve Livingston, MD, Lisa Townshend, ANP. Primary Care Provider: Liver Disease & Hepatitis Program Providers: Brian McMahon, MD, Steve Livingston, MD, Lisa Townshend, ANP Primary Care Provider: If you are considering hepatitis C treatment, please read this treatment

More information

Y O U R S U R G E O N S. choice of. implants F O R Y O U R S U R G E R Y

Y O U R S U R G E O N S. choice of. implants F O R Y O U R S U R G E R Y Y O U R S U R G E O N S choice of implants F O R Y O U R S U R G E R Y Y O U R S U R G E O N S choice of implants F O R Y O U R S U R G E R Y Your Surgeon Has Chosen the C 2 a-taper Acetabular System The

More information

INTRODUCTION Thrombophilia deep vein thrombosis DVT pulmonary embolism PE inherited thrombophilia

INTRODUCTION Thrombophilia deep vein thrombosis DVT pulmonary embolism PE inherited thrombophilia INTRODUCTION Thrombophilia (Hypercoagulability) is a condition in which a person forms blood clots more than normal. Blood clots may occur in the arms or legs (e.g., deep vein thrombosis DVT), the lungs

More information

Pregnancy and Substance Abuse

Pregnancy and Substance Abuse Pregnancy and Substance Abuse Introduction When you are pregnant, you are not just "eating for two." You also breathe and drink for two, so it is important to carefully consider what you put into your

More information

Committee Approval Date: September 12, 2014 Next Review Date: September 2015

Committee Approval Date: September 12, 2014 Next Review Date: September 2015 Medication Policy Manual Policy No: dru361 Topic: Pradaxa, dabigatran Date of Origin: September 12, 2014 Committee Approval Date: September 12, 2014 Next Review Date: September 2015 Effective Date: November

More information

MEDICATION GUIDE KOMBIGLYZE XR (kom-be-glyze X-R) (saxagliptin and metformin HCl extended-release) tablets

MEDICATION GUIDE KOMBIGLYZE XR (kom-be-glyze X-R) (saxagliptin and metformin HCl extended-release) tablets MEDICATION GUIDE KOMBIGLYZE XR (kom-be-glyze X-R) (saxagliptin and metformin HCl extended-release) tablets Read this Medication Guide carefully before you start taking KOMBIGLYZE XR and each time you get

More information

IMPORTANT DRUG WARNING Regarding Mycophenolate-Containing Products

IMPORTANT DRUG WARNING Regarding Mycophenolate-Containing Products Dear Healthcare Provider: Mycophenolate REMS (Risk Evaluation and Mitigation Strategy) has been mandated by the FDA (Food and Drug Administration) due to postmarketing reports showing that exposure to

More information

Bayer Pharma AG 13342 Berlin Germany Tel. +49 30 468-1111 www.bayerpharma.com. News Release. Not intended for U.S. and UK Media

Bayer Pharma AG 13342 Berlin Germany Tel. +49 30 468-1111 www.bayerpharma.com. News Release. Not intended for U.S. and UK Media News Release Not intended for U.S. and UK Media Bayer Pharma AG 13342 Berlin Germany Tel. +49 30 468-1111 www.bayerpharma.com Bayer Forms Collaboration with Academic and Governmental Institutions for Rivaroxaban

More information

A Patient s Guide to Antithrombotic Therapy in Atrial Fibrillation

A Patient s Guide to Antithrombotic Therapy in Atrial Fibrillation Patient s Guide to Antithrombotic Therapy in Atrial Fibrillation A Patient s Guide to Antithrombotic Therapy in Atrial Fibrillation PATIENT EDUCATION GUIDE What is atrial fibrillation? Atrial fibrillation

More information

Key Facts about Influenza (Flu) & Flu Vaccine

Key Facts about Influenza (Flu) & Flu Vaccine Key Facts about Influenza (Flu) & Flu Vaccine mouths or noses of people who are nearby. Less often, a person might also get flu by touching a surface or object that has flu virus on it and then touching

More information

Algorithm for Initiating Antidepressant Therapy in Depression

Algorithm for Initiating Antidepressant Therapy in Depression Algorithm for Initiating Antidepressant Therapy in Depression Refer for psychotherapy if patient preference or add cognitive behavioural office skills to antidepressant medication Moderate to Severe depression

More information

PHARMACOLOGY UPDATE: BOOMER DRUGS

PHARMACOLOGY UPDATE: BOOMER DRUGS PHARMACOLOGY UPDATE: BOOMER DRUGS Sandra Brownstein, PharmD Evercare Clinical Pharmacy Director West Region Objectives: Review the new drugs that have recently been approved by the FDA Determine the role

More information

Overview of Mental Health Medication Trends

Overview of Mental Health Medication Trends America s State of Mind Report is a Medco Health Solutions, Inc. analysis examining trends in the utilization of mental health related medications among the insured population. The research reviewed prescription

More information

A Patient s Guide to Primary and Secondary Prevention of Cardiovascular Disease Using Blood-Thinning (Anticoagulant) Drugs

A Patient s Guide to Primary and Secondary Prevention of Cardiovascular Disease Using Blood-Thinning (Anticoagulant) Drugs A Patient s Guide to Primary and Secondary Prevention of PATIENT EDUCATION GUIDE What Is Cardiovascular Disease? Cardiovascular disease (CVD) is a broad term that covers any disease of the heart and circulatory

More information

Introduction. Background to this event. Raising awareness 09/11/2015

Introduction. Background to this event. Raising awareness 09/11/2015 Introduction Primary Care Medicines Governance HSCB Background to this event New class of medicines Availability of training Increasing volume of prescriptions Reports of medication incidents Raising awareness

More information

Licence for use in the UK is expected before the end of 2011

Licence for use in the UK is expected before the end of 2011 News Release FOR UK HEALTHCARE MEDIA ONLY Bayer HealthCare Bayer plc Bayer House Strawberry Hill Newbury Berkshire, RG14 1JA www.bayer.co.uk Bayer s Xarelto (rivaroxaban) Recommended by CHMP for EU Approval

More information

DVT/PE Management with Rivaroxaban (Xarelto)

DVT/PE Management with Rivaroxaban (Xarelto) DVT/PE Management with Rivaroxaban (Xarelto) Rivaroxaban is FDA approved for the acute treatment of DVT and PE and reduction in risk of recurrence of DVT and PE. FDA approved indications: Non valvular

More information

POSTPARTUM DEPRESSION: A Guide for Patients and Families

POSTPARTUM DEPRESSION: A Guide for Patients and Families POSTPARTUM DEPRESSION: A Guide for Patients and Families Margaret L. Moline, PhD, David A. Kahn, MD, Ruth W. Ross, MA, Lori L. Altshuler, MD, and Lee S. Cohen, MD www.womensmentalhealth.org The birth of

More information

INITIATING ORAL AUBAGIO (teriflunomide) THERAPY

INITIATING ORAL AUBAGIO (teriflunomide) THERAPY FOR YOUR PATIENTS WITH RELAPSING FORMS OF MS INITIATING ORAL AUBAGIO (teriflunomide) THERAPY WARNING: HEPATOTOXICITY AND RISK OF TERATOGENICITY Severe liver injury including fatal liver failure has been

More information

Electroconvulsive Therapy - ECT

Electroconvulsive Therapy - ECT Electroconvulsive Therapy - ECT Introduction Electroconvulsive therapy, or ECT, is a safe and effective treatment that may reduce symptoms related to depression or mental illness. During ECT, certain parts

More information

Major Depression. What is major depression?

Major Depression. What is major depression? Major Depression What is major depression? Major depression is a serious medical illness affecting 9.9 million American adults, or approximately 5 percent of the adult population in a given year. Unlike

More information

MEDICATION GUIDE ACTOPLUS MET (ak-tō-plus-met) (pioglitazone hydrochloride and metformin hydrochloride) tablets

MEDICATION GUIDE ACTOPLUS MET (ak-tō-plus-met) (pioglitazone hydrochloride and metformin hydrochloride) tablets MEDICATION GUIDE (ak-tō-plus-met) (pioglitazone hydrochloride and metformin hydrochloride) tablets Read this Medication Guide carefully before you start taking and each time you get a refill. There may

More information

Management in the pre-hospital setting

Management in the pre-hospital setting Management in the pre-hospital setting Inflammation of the joints Two main types: Osteoarthritis - cartilage loss from wear and tear Rheumatoid arthritis - autoimmune disorder Affects all age groups,

More information

MEDICAL ASSISTANCE HANDBOOK PRIOR AUTHORIZATION OF PHARMACEUTICAL SERVICES. A. Prescriptions That Require Prior Authorization

MEDICAL ASSISTANCE HANDBOOK PRIOR AUTHORIZATION OF PHARMACEUTICAL SERVICES. A. Prescriptions That Require Prior Authorization MEDICAL ASSISTANCE HBOOK PRI AUTHIZATION OF PHARMACEUTICAL SERVICES I. Requirements for Prior Authorization of Anticoagulants A. Prescriptions That Require Prior Authorization Prescriptions for Anticoagulants

More information

Informed Consent for Laparoscopic Vertical Sleeve Gastrectomy. Patient Name

Informed Consent for Laparoscopic Vertical Sleeve Gastrectomy. Patient Name Informed Consent for Laparoscopic Vertical Sleeve Gastrectomy Patient Name Please read this form carefully and ask about anything you may not understand. I consent to have a laparoscopic Vertical Sleeve

More information

Multiple Myeloma. This reference summary will help you understand multiple myeloma and its treatment options.

Multiple Myeloma. This reference summary will help you understand multiple myeloma and its treatment options. Multiple Myeloma Introduction Multiple myeloma is a type of cancer that affects white blood cells. Each year, thousands of people find out that they have multiple myeloma. This reference summary will help

More information

MEDGUIDE SECTION. What is the most important information I should know about SEROQUEL? SEROQUEL may cause serious side effects, including:

MEDGUIDE SECTION. What is the most important information I should know about SEROQUEL? SEROQUEL may cause serious side effects, including: MEDGUIDE SECTION Medication Guide SEROQUEL (SER-oh-kwell) (quetiapine fumarate) Tablets Read this Medication Guide before you start taking SEROQUEL and each time you get a refill. There may be new information.

More information

Acute Myeloid Leukemia

Acute Myeloid Leukemia Acute Myeloid Leukemia Introduction Leukemia is cancer of the white blood cells. The increased number of these cells leads to overcrowding of healthy blood cells. As a result, the healthy cells are not

More information

11 Serious and life-threatening side effects can occur while taking EVISTA. These include 12 blood clots and dying from stroke:

11 Serious and life-threatening side effects can occur while taking EVISTA. These include 12 blood clots and dying from stroke: 1 1 BNL 3123 AMP 2 Medication Guide 3 EVISTA (E-VISS-tah) 4 (raloxifene hydrochloride) 5 Tablets for Oral Use 6 Read the Medication Guide that comes with EVISTA before you start taking it and each time

More information

Performance Measurement for the Medicare and Medicaid Eligible (MME) Population in Connecticut Survey Analysis

Performance Measurement for the Medicare and Medicaid Eligible (MME) Population in Connecticut Survey Analysis Performance Measurement for the Medicare and Medicaid Eligible (MME) Population in Connecticut Survey Analysis Methodology: 8 respondents The measures are incorporated into one of four sections: Highly

More information

Paxil/Paxil-CR (paroxetine)

Paxil/Paxil-CR (paroxetine) Generic name: Paroxetine Available strengths: 10 mg, 20 mg, 30 mg, 40 mg tablets; 10 mg/5 ml oral suspension; 12.5 mg, 25 mg, 37.5 mg controlled-release tablets (Paxil-CR) Available in generic: Yes, except

More information

Remeron (mirtazapine)

Remeron (mirtazapine) Remeron (mirtazapine) FDA ALERT [07/2005] Suicidal Thoughts or Actions in Children and Adults Patients with depression or other mental illnesses often think about or attempt suicide. Closely watch anyone

More information

MEDICATION GUIDE Savella (Sa-vel-la) (milnacipran HCl) Tablets

MEDICATION GUIDE Savella (Sa-vel-la) (milnacipran HCl) Tablets MEDICATION GUIDE Savella (Sa-vel-la) (milnacipran HCl) Tablets Savella is not used to treat depression, but it acts like medicines that are used to treat depression (antidepressants) and other psychiatric

More information

The following is a sample of psychotropic drug warnings that drug regulatory agencies

The following is a sample of psychotropic drug warnings that drug regulatory agencies Chronology of International Drug Regulatory Agency Warnings about Psychotropic Drugs The following is a sample of psychotropic drug warnings that drug regulatory agencies around the world have issued.

More information

Male New Patient Package

Male New Patient Package Male New Patient Package The contents of this package are your first step to restore your vitality. Please take time to read this carefully and answer all the questions as completely as possible. Thank

More information

Summary of the risk management plan (RMP) for Otezla (apremilast)

Summary of the risk management plan (RMP) for Otezla (apremilast) EMA/741412/2014 Summary of the risk management plan (RMP) for Otezla (apremilast) This is a summary of the risk management plan (RMP) for Otezla, which details the measures to be taken in order to ensure

More information

HERTFORDSHIRE MEDICINES MANAGEMENT COMMITTEE (HMMC) RIVAROXABAN RECOMMENDED see specific recommendations for licensed indications below

HERTFORDSHIRE MEDICINES MANAGEMENT COMMITTEE (HMMC) RIVAROXABAN RECOMMENDED see specific recommendations for licensed indications below Name: generic (trade) Rivaroxaban (Xarelto ) HERTFORDSHIRE MEDICINES MANAGEMENT COMMITTEE (HMMC) RIVAROXABAN RECOMMENDED see specific recommendations for licensed indications below What it is Indications

More information

Markham Stouffville Hospital

Markham Stouffville Hospital Markham Stouffville Hospital Adult Diabetes Education Frequently Asked Questions What is diabetes? Diabetes is a disease in which blood glucose levels are above normal. Most of the food we eat is turned

More information

Rivaroxaban to prevent blood clots for patients who have a lower limb plaster cast. Information for patients Pharmacy

Rivaroxaban to prevent blood clots for patients who have a lower limb plaster cast. Information for patients Pharmacy Rivaroxaban to prevent blood clots for patients who have a lower limb plaster cast Information for patients Pharmacy Your doctor has prescribed a tablet called rivaroxaban. This leaflet tells you about

More information

Summary of the risk management plan (RMP) for Ionsys (fentanyl)

Summary of the risk management plan (RMP) for Ionsys (fentanyl) EMA/764409/2015 Summary of the risk management plan (RMP) for Ionsys (fentanyl) This is a summary of the risk management plan (RMP) for Ionsys, which details the measures to be taken in order to ensure

More information

NEURO-OPHTHALMIC QUESTIONNAIRE NAME: AGE: DATE OF EXAM: CHART #: (Office Use Only)

NEURO-OPHTHALMIC QUESTIONNAIRE NAME: AGE: DATE OF EXAM: CHART #: (Office Use Only) PAGE 1 NEURO-OPHTHALMIC QUESTIONNAIRE NAME: AGE: DATE OF EXAM: CHART #: (Office Use Only) 1. What is the main problem that you are having? (If additional space is required, please use the back of this

More information

What You Need to KnowWhen Taking Anticoagulation Medicine

What You Need to KnowWhen Taking Anticoagulation Medicine What You Need to KnowWhen Taking Anticoagulation Medicine What are anticoagulant medicines? Anticoagulant medicines are a group of medicines that inhibit blood clotting, helping to prevent blood clots.

More information

MEDICATION GUIDE WELLBUTRIN (WELL byu-trin) (bupropion hydrochloride) Tablets

MEDICATION GUIDE WELLBUTRIN (WELL byu-trin) (bupropion hydrochloride) Tablets MEDICATION GUIDE WELLBUTRIN (WELL byu-trin) (bupropion hydrochloride) Tablets Read this Medication Guide carefully before you start using WELLBUTRIN and each time you get a refill. There may be new information.

More information

UW MEDICINE PATIENT EDUCATION. Xofigo Therapy. For metastatic prostate cancer. What is Xofigo? How does it work?

UW MEDICINE PATIENT EDUCATION. Xofigo Therapy. For metastatic prostate cancer. What is Xofigo? How does it work? UW MEDICINE PATIENT EDUCATION Xofigo Therapy For metastatic prostate cancer This handout explains how the drug Xofigo is used to treat metastatic prostate cancer. What is Xofigo? Xofigo is a radioactive

More information

XARELTO (rivaroxaban tablets) in Knee and Hip Replacement Surgery

XARELTO (rivaroxaban tablets) in Knee and Hip Replacement Surgery XARELTO (rivaroxaban tablets) in Knee and Hip Replacement Surgery Fast Facts: XARELTO is a novel, once-daily, oral anticoagulant recently approved in the United States for the prevention (prophylaxis)

More information

MEDICATION GUIDE POMALYST (POM-uh-list) (pomalidomide) capsules. What is the most important information I should know about POMALYST?

MEDICATION GUIDE POMALYST (POM-uh-list) (pomalidomide) capsules. What is the most important information I should know about POMALYST? MEDICATION GUIDE POMALYST (POM-uh-list) (pomalidomide) capsules What is the most important information I should know about POMALYST? Before you begin taking POMALYST, you must read and agree to all of

More information

Treatment with Rivaroxaban

Treatment with Rivaroxaban UW MEDICINE PATIENT EDUCATION Treatment with Rivaroxaban Xarelto This handout explains the medicine rivaroxaban, a drug that helps prevent blood clots. What is rivaroxaban? Rivaroxaban (brand name Xarelto)

More information

Biologic Treatments for Rheumatoid Arthritis

Biologic Treatments for Rheumatoid Arthritis Biologic Treatments Rheumatoid Arthritis (also known as cytokine inhibitors, TNF inhibitors, IL 1 inhibitor, or Biologic Response Modifiers) Description Biologics are new class of drugs that have been

More information

Duration of Dual Antiplatelet Therapy After Coronary Stenting

Duration of Dual Antiplatelet Therapy After Coronary Stenting Duration of Dual Antiplatelet Therapy After Coronary Stenting C. DEAN KATSAMAKIS, DO, FACC, FSCAI INTERVENTIONAL CARDIOLOGIST ADVOCATE LUTHERAN GENERAL HOSPITAL INTRODUCTION Coronary artery stents are

More information

STRATTERA (Stra-TAIR-a)

STRATTERA (Stra-TAIR-a) 1 PV 5859 AMP MEDICATION GUIDE STRATTERA (Stra-TAIR-a) (atomoxetine) Capsules Read the Medication Guide that comes with STRATTERA before you or your child starts taking it and each time you get a refill.

More information

Preventing Blood Clots in Adult Patients. Information For Patients

Preventing Blood Clots in Adult Patients. Information For Patients Preventing Blood Clots in Adult Patients Information For Patients 1 This leaflet will give you information on how to reduce the risk of developing blood clots during and after your stay in hospital. If

More information

Daily aspirin therapy: Understand the benefits and risks

Daily aspirin therapy: Understand the benefits and risks Daily aspirin therapy: Understand the benefits and risks Is an aspirin a day the right thing for you? It's not as easy a decision as it sounds. Know the benefits and risks before considering daily aspirin

More information

Getting smart about dyspnea and life saving drug therapy in ACS patients. Kobi George Kaplan Medical Center Rehovot

Getting smart about dyspnea and life saving drug therapy in ACS patients. Kobi George Kaplan Medical Center Rehovot Getting smart about dyspnea and life saving drug therapy in ACS patients Kobi George Kaplan Medical Center Rehovot 78 year old female Case description Presented with resting chest pain and dyspnea Co morbidities:

More information

Antidepressants in Pregnancy D R S N E H A P A R G H I

Antidepressants in Pregnancy D R S N E H A P A R G H I Antidepressants in Pregnancy D R S N E H A P A R G H I Overview Depression and its effects Antidepressants and their effects Birth defects Miscarriage Neonatal withdrawal Longterm consequences Breastfeeding

More information

MEDICAL ASSISTANCE HANDBOOK PRIOR AUTHORIZATION OF PHARMACEUTICAL SERVICES. A. Prescriptions That Require Prior Authorization

MEDICAL ASSISTANCE HANDBOOK PRIOR AUTHORIZATION OF PHARMACEUTICAL SERVICES. A. Prescriptions That Require Prior Authorization MEDICAL ASSISTANCE HBOOK I. Requirements for Prior Authorization of Anticoagulants A. Prescriptions That Require Prior Authorization Prescriptions for Anticoagulants which meet any of the following conditions

More information

Medications for chronic pain

Medications for chronic pain Medications for chronic pain When it comes to treating chronic pain with medications, there are many to choose from. Different types of pain medications are used for different pain conditions. You may

More information

Secondary Stroke Prevention Luke Bradbury, MD 10/4/14 Fall WAPA Conferfence

Secondary Stroke Prevention Luke Bradbury, MD 10/4/14 Fall WAPA Conferfence Guidelines Secondary Stroke Prevention Luke Bradbury, MD 10/4/14 Fall WAPA Conferfence Stroke/TIA Nearly 700,000 ischemic strokes and 240,000 TIAs every year in the United States Currently, the risk for

More information

Developing Human Fetus

Developing Human Fetus Period Date LAB. DEVELOPMENT OF A HUMAN FETUS After a human egg is fertilized with human sperm, the most amazing changes happen that allow a baby to develop. This amazing process, called development, normally

More information

Anticoagulant therapy

Anticoagulant therapy Anticoagulation: The risks Anticoagulant therapy 1990 2002: 600 incidents reported 120 resulted in death of patient 92 deaths related to warfarin usage 28 reports related to heparin usage Incidents in

More information

Preventing Blood Clots After Hip or Knee Replacement Surgery or Surgery for a Broken Hip. A Review of the Research for Adults

Preventing Blood Clots After Hip or Knee Replacement Surgery or Surgery for a Broken Hip. A Review of the Research for Adults Preventing Blood Clots After Hip or Knee Replacement Surgery or Surgery for a Broken Hip A Review of the Research for Adults Is This Information Right for Me? Yes, if: You are considering or planning to

More information

Heroin. How Is Heroin Abused? How Does Heroin Affect the Brain? What Other Adverse Effects Does Heroin Have on Health?

Heroin. How Is Heroin Abused? How Does Heroin Affect the Brain? What Other Adverse Effects Does Heroin Have on Health? Heroin Heroin is an opiate drug that is synthesized from morphine, a naturally occurring substance extracted from the seed pod of the Asian opium poppy plant. Heroin usually appears as a white or brown

More information

Anticoagulation at the end of life. Rhona Maclean Rhona.maclean@sth.nhs.uk

Anticoagulation at the end of life. Rhona Maclean Rhona.maclean@sth.nhs.uk Anticoagulation at the end of life Rhona Maclean Rhona.maclean@sth.nhs.uk Content Anticoagulant Therapies Indications for anticoagulation Venous thromboembolism (VTE) Atrial Fibrillation Mechnical Heart

More information

Medication Guide EQUETRO (ē-kwĕ-trō) (carbamazepine) Extended-Release Capsules

Medication Guide EQUETRO (ē-kwĕ-trō) (carbamazepine) Extended-Release Capsules Medication Guide EQUETRO (ē-kwĕ-trō) (carbamazepine) Extended-Release Capsules Read this Medication Guide before you start taking EQUETRO and each time you get a refill. There may be new information. This

More information

A patient's guide. Your clinic's contact details are: Name: Contact number:

A patient's guide. Your clinic's contact details are: Name: Contact number: A patient's guide Your clinic's contact details are: Name: Contact number: Contents 2 Why have I been prescribed Xarelto? 2 What is Xarelto? 3 How do I take Xarelto? 3 What should I do if I miss a dose

More information

f AQ FREQUENTLY ASKED QUESTIONS FAQ065 WOMEN S HEALTH

f AQ FREQUENTLY ASKED QUESTIONS FAQ065 WOMEN S HEALTH The American College of Obstetricians and Gynecologists f AQ FREQUENTLY ASKED QUESTIONS FAQ065 WOMEN S HEALTH It s Time to Quit Smoking What are the dangers of smoking? How does smoking affect the body?

More information

MEDICATION GUIDE STELARA

MEDICATION GUIDE STELARA MEDICATION GUIDE STELARA (stel ar a) (ustekinumab) Injection What is the most important information I should know about STELARA? STELARA is a medicine that affects your immune system. STELARA can increase

More information

DCCT and EDIC: The Diabetes Control and Complications Trial and Follow-up Study

DCCT and EDIC: The Diabetes Control and Complications Trial and Follow-up Study DCCT and EDIC: The Diabetes Control and Complications Trial and Follow-up Study National Diabetes Information Clearinghouse U.S. Department of Health and Human Services NATIONAL INSTITUTES OF HEALTH What

More information

INFUSE Bone Graft. Patient Information Brochure

INFUSE Bone Graft. Patient Information Brochure INFUSE Bone Graft Patient Information Brochure This Patient Guide is designed to help you decide whether or not to have surgery using INFUSE Bone Graft to treat your broken tibia (lower leg). There are

More information

Other Noninfectious Diseases. Chapter 31 Lesson 3

Other Noninfectious Diseases. Chapter 31 Lesson 3 Other Noninfectious Diseases Chapter 31 Lesson 3 Diabetes Diabetes- a chronic disease that affects the way body cells convert food into energy. Diabetes is the seventh leading cause of death by disease

More information

Preventive Care Recommendations THE BASIC FACTS

Preventive Care Recommendations THE BASIC FACTS Preventive Care Recommendations THE BASIC FACTS MULTIPLE SCLEROSIS Carlos Healey, diagnosed in 2001 The Three Most Common Eye Disorders in Multiple Sclerosis Blood Pressure & Pulse Height & Weight Complete

More information

Facts About Chickenpox and Shingles for Adults

Facts About Chickenpox and Shingles for Adults Facts About Chickenpox and Shingles for Adults What is chickenpox? Chickenpox, also known as varicella, is a very contagious disease caused by the varicella-zoster virus. It is spread easily through the

More information

Depression in Older Persons

Depression in Older Persons Depression in Older Persons How common is depression in later life? Depression affects more than 6.5 million of the 35 million Americans aged 65 or older. Most people in this stage of life with depression

More information

Managing Anemia When You Are on Dialysis. Stage 5

Managing Anemia When You Are on Dialysis. Stage 5 Managing Anemia When You Are on Dialysis Stage 5 What is anemia? Anemia happens when your red blood cells are in short supply. Red blood cells carry oxygen from your lungs to all parts of your body, giving

More information

MEDICATION GUIDE JUXTAPID (JUKS-tuh-pid) (lomitapide) capsules

MEDICATION GUIDE JUXTAPID (JUKS-tuh-pid) (lomitapide) capsules MEDICATION GUIDE JUXTAPID (JUKS-tuh-pid) (lomitapide) capsules Read this Medication Guide before your treatment. What is the most important information I should know about JUXTAPID? JUXTAPID is available

More information

Medication Management of Depressive Disorders in Children and Adolescents. Satya Tata, M.D. Kansas University Medical Center

Medication Management of Depressive Disorders in Children and Adolescents. Satya Tata, M.D. Kansas University Medical Center Medication Management of Depressive Disorders in Children and Adolescents Satya Tata, M.D. Kansas University Medical Center First Line Medications SSRIs Prozac (Fluoxetine): 5-605 mg Zoloft (Sertraline):

More information

Further information You can get more information and share your experience at www.aboutmyhealth.org

Further information You can get more information and share your experience at www.aboutmyhealth.org OS01 Total Hip Replacement Further information You can get more information and share your experience at www.aboutmyhealth.org Local information You can get information locally from: Taunton and Somerset

More information

Ask Your Doctor if There May Be a SMARTER CHOICE

Ask Your Doctor if There May Be a SMARTER CHOICE If you have osteoarthritis, rheumatoid arthritis or ankylosing spondylitis, Could Your NSAID Pain Medicine Be Hurting Your Stomach? Ask Your Doctor if There May Be a SMARTER CHOICE 1 of 8 Making Smart

More information